Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
Sponsor: University Hospital Schleswig-Holstein
Summary
The goal is to explore whether the application of cannabis extract Avextra 10/10 solution is suitable to contribute to an improvement in the symptom burden and well-being of oncological palliative care patients. The primary objective of the study is to demonstrate the improvement in global symptom burden in the intervention arm compared to the placebo control group over a period of 12±2 days, as measured by a percentage change in the value of the Edmonton Symptom Assessment System total symptom distress score (ESAS TSDS) at baseline and after 12±2 days.
Official title: Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BEfindLichkeitsverbesserung Unter CANnabinoid-ExtrakTen Bei Onkologischen Patienten)
Key Details
Gender
All
Age Range
25 Years - Any
Study Type
INTERVENTIONAL
Enrollment
170
Start Date
2024-04-08
Completion Date
2026-11-30
Last Updated
2024-10-26
Healthy Volunteers
No
Interventions
Cannabisextrakt Avextra 10/10 Lösung
medical cannabinoids
Locations (4)
Hubertus Wald Tumorzentrum Universitäres Cancer Center Hamburg (UCCH)
Hamburg, Hamburg, Germany
University Hospital Schleswig-Holstein
Kiel, Schleswig-Holstein, Germany
University Hospital Schleswig-Holstein
Kiel, Schleswig-Holstein, Germany
University Hospital Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany